Vivo Capital, LLC Zai Lab LTD Transaction History

Vivo Capital, LLC

$683 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$15.95 - $26.8 $1.91 Million - $3.2 Million	119,521 Added 29.03%	531,198 $8.51 Million
Q4 2023 Feb 06, 2024	SELL	$22.97 - $30.58 $986,079 - $1.31 Million	-42,929 Reduced 9.44%	411,677 $11.3 Million
Q3 2023 Nov 08, 2023	BUY	$22.72 - $31.49 $206,774 - $286,590	9,101 Added 2.04%	454,606 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$25.3 - $39.67 $730,284 - $1.15 Million	28,865 Added 6.93%	445,505 $12.4 Million
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $2.35 Million - $3.75 Million	77,919 Added 23.0%	416,640 $13.9 Million
Q4 2022 Feb 13, 2023	BUY	$22.28 - $38.71 $1.5 Million - $2.6 Million	67,193 Added 24.75%	338,721 $10.4 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $2.08 Million - $4.47 Million	89,951 Added 49.54%	271,528 $9.42 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $182,671 - $423,623	6,578 Added 3.76%	181,577 $7.99 Million
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $105 - $178	-1 Reduced -0.0%	174,999 $18.4 Million
Q4 2020 Feb 16, 2021	BUY	$81.94 - $135.34 $4.33 Million - $7.16 Million	52,893 Added 43.32%	175,000 $23.7 Million
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $4.88 Million - $8.25 Million	-100,000 Reduced 45.02%	122,107 $10 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $8.68 Million - $14 Million	222,107 New	222,107 $11.4 Million
Q2 2019 Aug 13, 2019	SELL	$25.73 - $35.79 $1.84 Million - $2.56 Million	-71,595 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$21.71 - $31.54 $221,963 - $322,464	-10,224 Reduced 12.5%	71,595 $2.11 Million
Q4 2018 Feb 13, 2019	SELL	$14.95 - $24.72 $2.23 Million - $3.69 Million	-149,191 Reduced 64.58%	81,819 $1.9 Million
Q2 2018 Aug 10, 2018	SELL	$18.0 - $25.01 $949,986 - $1.32 Million	-52,777 Reduced 18.6%	231,010 $5.37 Million
Q1 2018 May 15, 2018	SELL	$20.05 - $26.96 $677,289 - $910,708	-33,780 Reduced 10.64%	283,787 $6.06 Million
Q4 2017 Feb 09, 2018	SELL	$21.23 - $34.09 $157,802 - $253,390	-7,433 Reduced 2.29%	317,567 $6.74 Million
Q3 2017 Nov 13, 2017	BUY	$27.0 - $31.11 $8.78 Million - $10.1 Million	325,000	325,000 $8.78 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

Janus Henderson Group PLC London, X0

8.76M
Shares

$217 Million
0.11% of portfolio
Wellington Management Group LLP Boston, MA

8.44M
Shares

$209 Million
0.04% of portfolio
Capital World Investors Los Angeles, CA

6.44M
Shares

$160 Million
0.02% of portfolio
Viking Global Investors LP

1.95M
Shares

$48.4 Million
0.18% of portfolio
Bamco Inc New York, NY

1.91M
Shares

$47.3 Million
0.13% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.43B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Account